Elliot Newman

  • Specialties: Surgical Oncology, General Surgery
  • Languages: English, Hebrew
  • Phone: 212-731-5466

About Me

My fascination with the science behind cancer and the ability of oncologists to positively impact people’s lives drew me to surgical oncology.

At Perlmutter Cancer Center, I treat people who have gastrointestinal cancer, pancreatic cancer, stomach cancer, colon cancer, liver cancer, and bile duct cancer. I also care for people with less common types of cancers, such as retroperitoneal tumors, sarcomas, and adrenal tumors.

Everyone here is driven by the ability to care for others, and we work as a team to ensure that patients’ experiences are as seamless as possible. They have direct contact with my colleagues and myself.

Cancer has always been a complicated disease, often requiring treatment by many doctors of different specialties. When people come to see us for treatment, they may see oncologists, gastroenterologists, and radiation oncologists, in addition to other experts, who all weigh in on their care and help to develop a detailed treatment plan.

We know that cancer care is not one-size-fits-all. We recognize how important it is to listen carefully to what each person says, analyze the problem from the perspective of our specialty, and then tailor treatment specifically to each person.

We’ve seen great advances in cancer care at NYU Langone. In terms of surgical technique, we are very focused on minimally invasive surgical approaches and robotic-assisted surgery. Technology within our Robotic Surgery Center aids us in using minimally invasive approaches for colorectal cancer, pancreatic cancer, and stomach cancer.

For some people, minimally invasive surgery can be incredibly helpful. These procedures can speed up recovery, allowing people to leave the hospital sooner and move on to additional treatments, such as chemotherapy or radiation therapy, more quickly.

In terms of cancer treatment, we continue to enlarge our portfolio of clinical trials and study advanced treatments. My research focuses on pancreatic cancer and gastric cancer. Our clinical trials test the effectiveness of treatments and therapies before surgery and after surgery. I also work with basic scientists to study tumors, in the hope of finding new treatments for people who have advanced cancer that cannot be managed with surgery.


Conditions and Treatments

gastrointestinal cancer, pancreatic cancer, stomach cancer, colon cancer, colorectal cancer, cancer surgery, gastrointestinal surgery, pancreas surgery, liver surgery, minimally invasive surgery, gallbladder surgery, excision of the spleen, robotic surgery, robotic assisted surgery
Show More Conditions

Credentials

Positions
  • Professor, Department of Surgery
Education and Training
  • Fellowship, Memorial Sloan-Kettering Cancer Center, Surgery Oncology, 1995
  • Residency, NYU Medical Center, Surgery, 1993
  • Fellowship, Memorial Sloan-Kettering Cancer Center, Surgery Oncology, 1991
  • Residency, NYU Medical Center, Surgery (General), 1989
Departments

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Affinity
    • Affinity
    • Affinity Exchange- Essential
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
    • ElderPlan
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Family Health
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
    • GHI CBP
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP EPO/PPO
    • HIP HMO
    • HIP Medicare
    • HIP POS
  • HealthSmart
    • HealthSmart (WTC)
  • Humana
    • Humana Medicare
  • Local 1199
    • Local 1199 PPO
  • MagnaCare
    • MagnaCare PPO
  • Medicaid
    • NY Medicaid
  • Medicare
    • Medicare
  • MetroPlus
    • MetroPlus Child Health
    • MetroPlus Essential
    • MetroPlus Exchange Plans
    • MetroPlus Family Health
    • MetroPlus Medicaid
    • MetroPlus Medicare
  • MultiPlan/PHCS
    • MultiPlan/PHCS PPO
  • Oscar
    • Oscar
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
    • Oxford Mosaic
  • Railroad Medicare
    • Railroad Medicare
  • Tricare
    • Tricare
  • UHC
    • UnitedHealthcare Community & State Plan
    • UnitedHealthcare Core and Charter
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • UPN
    • UPN Elite
  • VNS
    • Visiting Nurse Service (VNS) Medicare
  • Village Caremax
    • Village Caremax
  • WellCare
    • WellCare Child Health
    • WellCare Family Health
    • WellCare Medicaid
    • WellCare Medicare
  • Wellcare
    • Wellcare Exchange
NYU General Surgery Associates

160 East 34th Street, 9th Floor
New York, NY 10016

Contact

Phone: 212-731-5466

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

Publications

  • Changes in Apparent Diffusion Coefficient Evaluated with Diffusion Weighted MRI May Predict Complete Pathologic Response After Neoadjuvant Therapy for Rectal Cancer: A Meta-analysis [Meeting Abstract]

    Desiato, V; Rosman, A; Newman, E; Berman, R; Pachter, H; Melis, M Desiato, V; Rosman, A; Newman, E; Berman, R; Pachter, H; Melis, M
    Annals of surgical oncology. 2016 FEB. 23: S90-S90

  • Changes in apparent diffusion coefficient evaluated with diffusion-weighted MRI to predict complete pathologic response after neoadjuvant therapy for rectal cancer: Literature review and meta-analysis. [Meeting Abstract]

    Desiato, Vincenzo; Rosman, Alan S; Newman, Elliot; Berman, Russell S; Pachter, HLeon; Melis, Marcovalerio Desiato, Vincenzo; Rosman, Alan S; Newman, Elliot; Berman, Russell S; Pachter, HLeon; Melis, Marcovalerio
    Journal of clinical oncology. 2016 FEB 1. 34 (4): ?-?

  • Adjuvant Radiation Therapy in Patients Undergoing Curative Intent Resection for Adrenocortical Carcinoma: A Multi-Institutional Experience [Meeting Abstract]

    Hatzaras, I; Rao, R; Tran, TB; Postlewait, LM; Maithel, SK; Prescott, J; Pawlik, TM; Wang, T; Phay, J; Fields, RC; Jin, L; Weber, S; Salem, AI; Sicklick, J; Gad, S; Yopp, A; Mansour, J; Duh, Q; Seiser, N; Solorzano, CC; Kiernan, CM; Votanopoulos, K; Levine, EA; Newman, E; Poultsides, G; Pachter, H Hatzaras, I; Rao, R; Tran, TB; Postlewait, LM; Maithel, SK; Prescott, J; Pawlik, TM; Wang, T; Phay, J; Fields, RC; Jin, L; Weber, S; Salem, AI; Sicklick, J; Gad, S; Yopp, A; Mansour, J; Duh, Q; Seiser, N; Solorzano, CC; Kiernan, CM; Votanopoulos, K; Levine, EA; Newman, E; Poultsides, G; Pachter, H
    Annals of surgical oncology. 2016 FEB. 23: S99-S99

Read All Publications (63)